| abstract |
A novel gene therapy agent having an angiogenic action is provided. A gene encoding a polypeptide having both the amino acid sequence of a polypeptide having fibroblast growth factor activity and the amino acid sequence of a polypeptide having cell adhesion activity, a medicament comprising the gene, and a vector having the gene A pharmaceutical comprising the vector. A polypeptide having both an amino acid sequence of a secretory signal, an amino acid sequence of a polypeptide having fibroblast growth factor activity, and an amino acid sequence of a polypeptide having cell adhesion activity, a pharmaceutical comprising the polypeptide, and encoding the polypeptide A gene, a medicament comprising the gene, a vector having the gene, and a medicament comprising the vector. [Selection figure] None |